Onderneming Integrated BioPharma, Inc. Other OTC
Aandelen
INBP
US45811V1052
Farmaceutische producten
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Contract Manufacturing
95,3
%
| 54 | 96,2 % | 48 | 95,3 % | -10,75% |
Other Nutraceutical Businesses
4,7
%
| 2 | 3,8 % | 2 | 4,7 % | +11,14% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
84,1
%
| 47 | 82,7 % | 43 | 84,1 % | -8,38% |
International
15,9
%
| 10 | 17,3 % | 8 | 15,9 % | -17,21% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Riva Sheppard
CEO | Chief Executive Officer | 57 | 01-05-91 |
Christina Kay
CEO | Chief Executive Officer | 54 | 01-12-94 |
Dina Masi
DFI | Director of Finance/CFO | 63 | 17-11-05 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Christina Kay
CEO | Chief Executive Officer | 54 | 01-12-94 |
Damon Desantis
BRD | Director/Board Member | 56 | 20-06-22 |
Eric Friedman
BRD | Director/Board Member | 76 | 04-11-20 |
Riva Sheppard
CEO | Chief Executive Officer | 57 | 01-05-91 |
Robert Canarick
BRD | Director/Board Member | 74 | 01-12-94 |
William Milmoe
BRD | Director/Board Member | 76 | 18-12-08 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 30 134 510 | 6 092 115 ( 20,22 %) | 34 900 ( 0,1158 %) | 20,22 % |
Bedrijfsgegevens
![Adres Integrated BioPharma, Inc.(INBP)](https://cdn.zonebourse.com/static/address/11095175.png)
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+55,32% | 819 mld. | |
-6,75% | 351 mld. | |
+13,56% | 329 mld. | |
+10,68% | 298 mld. | |
+16,57% | 242 mld. | |
+2,04% | 225 mld. | |
+13,31% | 217 mld. | |
+8,48% | 168 mld. | |
-2,81% | 158 mld. |